CLYM
Climb Bio
CLYM
CLYM
22 hedge funds and large institutions have $47.8M invested in Climb Bio in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.13M | |
| 2 | +$132K | |
| 3 | +$112K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$10.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.65K |
Top Sellers
| 1 | -$1M | |
| 2 | -$492K | |
| 3 | -$474K | |
| 4 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$203K |
| 5 |
E
Ergoteles
New York
|
-$80K |